Delft-based company Vivici, an innovator in B2B dairy protein through precision fermentation, has raised €32M in Series A funding aimed at broadening its market reach and launching new products. Investors, including APG and Invest-NL, showcase confidence in Vivici’s ability to meet the demand for sustainable, animal-free dairy proteins. CEO Stephan van Sint Fiet highlighted that the funding will help commercialize precision fermentation effectively. The company’s first ingredient, Vivitein BLG, symbolizes a shift towards a new standard in protein that prioritizes sustainability and nutrition without animal involvement.
Vivici's recent €32M Series A funding will enable the company to expand into international markets and develop new dairy protein ingredients through precision fermentation.
CEO Stephan van Sint Fiet stated that this investment reflects investors' confidence in their mission to commercialize precision fermentation as a viable industry.
Vivici’s first product, Vivitein BLG, is isolated whey protein, aiming to deliver sustainable protein without the need for animal involvement.
Backed by dsm-firmenich and Fonterra, Vivici is set to establish a new standard in protein production that emphasizes sustainability and consumer benefits.
Collection
[
|
...
]